TrialCancer prevention research (Philadelphia, Pa.)2012

A phase 2 cancer chemoprevention biomarker trial of isoflavone G-2535 (genistein) in presurgical bladder cancer patients.

Edward Messing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.